MRI Technologist

Am I rich enough to pay for my own full-body MRI scan for peace of mind? Private clinics market MRI scans as a tool to detect abnormalities and 'silent killers' lurking inside asymptomatic bodies Published Sep 16, 2026 Last updated 8 hours ago Sonia Keuroghlian's husband, a radiologist, has seen cancer in people in their 20s and 30s, younger than the ages recommended for most publicly funded cancer screening. So, when the Toronto couple turned 40, he suggested they undergo full-body MRI (magnetic resonance imaging) scans at a private clinic in Vancouver, where her husband is from, and where they were vacationing in August 2018, "just to make sure everything is OK," Keuroghlian said. She was healthy, active, fit, and feeling perfectly normal, which is why, when the radiologist later pulled up an image of a 10.5-centimetre tumour attached to the outside of her stomach, "my world turned upside down," said Keuroghlian, a corporate lawyer. "I had two kids at the time; they were six and eight. And the craziest part is that I didn't feel anything." The tumor, she was told, was like a water ballon "that squeezes its way between organs, so it moves with you and you don't really feel it until it's grown to the point where it's attached to other organs." What followed was a "whole bunch of other imaging" back in Toronto and, later, laparoscopic surgery to remove the gastrointestinal tumour. "I was lucky because it hadn't metastasized, so I didn't need chemo or radiation." Eight years and a third child later, she's cancer free. "I feel so lucky that we caught it when we did." Keuroghlian had her scan with Prenuvo, a Canadian-founded and now California-based provider of "proactive" whole body screening endorsed by Kate Hudson, Kim Kardashian and Jason Bateman. To the chagrin of many medical groups who argue there is no sufficient evidence full-body scans are effective at prolonging life, the pricey scans are gaining popularity, with Prenuvo alone surpassing the 200,000-scans mark since setting up its first clinic in Vancouver in 2018, later expanding into California's Silicon Valley and then across the United States. Prenuvo founder and CEO Andrew Lacy said some clients have a family history of cancer or disease and are seeking screening "for peace of mind." "We're able to pick up these conditions early - in the case of cancer, typically when it's still localized to the organ of origin and when the patient is still asymptomatic." Others have indeterminate symptoms that aren't being "quickly or easily resolved by the health system and they want to go and get the most advanced screening they can, to get to an answer to the problem." Lacy said "proactive health care," as a sector, is growing 30 per cent a year. "We would love to be operating in more Canadian markets. There's certainly tremendous demand." How much do MRI scans cost? For a fee - roughly $2,500 to $3,000 at private clinics - the scans are marketed as a tool to detect diseases and abnormalities lurking inside asymptomatic bodies. In its promotional material, Prenuvo says whole body MRI can detect brain aneurysms at risk of rupture, kidney cancers, degenerative disc disease, adrenal masses, lymphoma and a host of other conditions. The company offers full body scans for $2,999, and faster (under 30 minutes) head-to-mid-thigh scans for $1.499. Prenuvo memberships start at around $1700, and include the faster scan. Whole Body MRI in Ontario has two locations where opting for a scan not only benefits the body but also "peace of mind," according to the company website. Their "signature" head/neck-to-knee scan costs $3,250; a $3,650 package includes a comprehensive blood work up. Where can you get them? In addition to clinics in major American cities, Prenuvo launched a mobile clinic near the U.S.-Canada border in Buffalo two years ago to meet what it described as a growing waitlist of Canadians. Restrictions on private imaging services in Ontario have so far stalled efforts to open a clinic in Toronto. "When we opened our Buffalo clinic, over 10,000 Canadians joined the waitlist," said Prenuvo spokeswoman Christine Alabastro. "At peak, nearly 80 per cent of its patients were crossing the border from Canada. "Those numbers highlight the gap between what Canadians want and what the current system offers them." Who is getting them? Full-body scans are marketed as "empowering," a way to shift from a passive - let's wait for symptoms to appear - to proactive - let's get ahead of things - approach. They appeal to the "preventive medicine-oriented crowd," said Dr. Dan Durand, chief medical officer at Prenuvo. When they first started out in Silicon Valley, clients were predominantly male biohacker types. Today, Prenuvo patients skew more female (close to 60 per cent) than male. Eighty per cent, regardless of sex, come without symptoms. Most have no chief complaints, though Canadian patients tend to be slightly older, and slightly sicker, often coming because of long MRI waitlists at home. How does it work? The scan takes roughly 40 to 100 minutes, depending on the package purchased. People must fast for several hours ahead of time. They're given earplugs, headphones or both, to lessen noise from the thumping, knocking and banging from the magnetic fields generated. Organs scanned include the brain, spine, lung, liver, gallbladder, spleen, bladder, pancreas, ovaries and uterus in women, and prostate in men. Days later, people receive the results that are then discussed in a follow-up with a nurse practitioner or other licensed provider, Durand said. "It's like a 30-page book, your personal owner's manual." The scans can show "normal" or "informational findings," he explained. Other times the scans detect things of "moderate severity," like early signs of arthritis or fat in the liver. "It isn't like something you're going to need to see the doctor about immediately," unless, say, it's a high degree of fatty liver. Is it worth it? Professional organizations such as the Canadian Association of Radiologists, among others, strongly oppose whole-body MRI screening in symptom-free people. "There is no compelling evidence from high-quality studies demonstrating that whole-body MRI screening in asymptomatic individuals improves long-term health outcomes, reduces morbidity or mortality or leads to better health at the population level," reads the Canadian radiologists policy statement. Among the concerns are the risk of false positives and "incidentalomas" - masses or tumours of uncertain or dubious significance that often require more invasive testing, biopsies or even surgeries to rule out, shifting the burden of follow-up to the publicly funded system. Quick Picks A recent article published in Canadian Family Physician reported that, based on two systematic reviews, 94 per cent of asymptomatic adults who undergo whole-body MRI (WBMRI) screening for cancer will have a "radiologic abnormality," up to 30 per cent will require follow-up investigations and 1.1 to 1.6 per cent will have a confirmed cancer. Information on the number and causes of death were not available, there are no randomized controlled studies comparing people who received whole-body MRI for cancer screening to people who did not, and it's not known how many people who had a negative test result "ended up having cancer," the Alberta authors wrote. "WBMRI for cancer screening in asymptomatic adults should not be encouraged," they concluded. Prenuvo's Durand said the scans aren't meant to replace primary care or other screening tests, like publicly funded screening in Canada for breast, prostate and cervical cancer. "We never want to be viewed as saying that stuff is being replaced by us," he said. Prenuvo is, however, facing a lawsuit filed by a New York man who alleges a radiologist failed to spot signs of a narrowing and irregularity in a cerebral artery that led to a stroke eight months later, an allegation the company has reportedly denied in court filings, Radiology Business reported. Before Keuroghlian's own scan, friends wondered, why bother? "Afterwards, they all started flying to Vancouver to get scans because they couldn't believe what happened." Keuroghlian said neither she nor her husband have received compensation or free scans for speaking to the media about her experience with a private clinic MRI. She recently did a TV interview and said she wasn't even reimbursed for having to park her car for the day. "There's always this debate whether it's OK to have private health care and is it excluding people (who can't afford it). I don't have a full answer to that, but one thing I can say: If I had not found out when I did and (the cancer) was detected later when it was more serious requiring more invasive surgery and chemo, and God knows what would have happened to my qualify of life, that would have cost (Ontario's public insurance plan) a lot more than having laparoscopic surgery to remove the tumour" before it became more widespread, she said. National Post Grand summer memories start here.Grand pool. Grand sunsets. Grand memories. 10 restaurants, 17 bars, and pristine beaches. An all-inclusive summer in Montego Bay, Jamaica.Palladium Hotel Group | Sponsored Join the Conversation Postmedia is committed to maintaining a lively but civil forum for discussion. Please keep comments relevant and respectful. Comments may take up to an hour to appear on the site. You will receive an email if there is a reply to your comment, an update to a thread you follow or if a user you follow comments. Visit its Community Guidelines for more information. Latest from Shopping Essentials

Function Health nets $450M for preventive care. Table of contents. More than 100 million Americans do not have a primary care doctor. For those who do, the average wait for an appointment now stretches to 31 days. Three in four U.S. adults are managing at least one chronic condition, and 90% of the United States' $4.9 trillion in annual healthcare spending goes toward treating diseases that are often detectable years before symptoms appear. Function, the Austin-based health-testing platform, wants to prove there's a cheaper argument to be had, backed now by a substantial Function Health General Catalyst funding round. The scale of this Function Health General Catalyst funding deal. Function has secured $450 million in growth financing from General Catalyst's Customer Value Fund, the venture firm's non-dilutive vehicle that ties capital to customer growth rather than equity. It is one of CVF's largest deals to date, following a similar $200 million commitment to healthcare AI platform Commure in June 2025. What Function's platform actually offers. Founded in 2021 by Jonathan Swerdlin, Pranitha Patil, Dr. Mark Hyman, Seth Weisfeld, Mike Nemke, and Dan Swerdlin, Function combines more than 160 lab tests, roughly five times what a standard annual physical covers, with advanced imaging designed to catch early signs of cancer, aneurysms, stroke, and hundreds of other conditions, all inside a single annual membership priced at $365, or a dollar a day. Function's growth since launch. Since launching its beta in 2023, the company says it has grown to more than 500,000 members and completed over 100 million lab tests, according to the company. "Our mission is simple: enable you to live 100 healthy years. Everyone deserves to feel their best and avoid suffering. This growth financing allows us to bring that future of health into the present," said Swerdlin, Function's co-founder and chief executive. Recent acquisitions behind this Function Health General Catalyst funding. The financing landed months after two acquisitions that filled out Function's platform: Getlabs, which brought nationwide at-home and office blood draws, and SuppCo, whose TrustScore system rates the reliability of over-the-counter supplements. Neither deal disclosed terms. Function also acquired MRI scanning platform Ezra in May 2025, giving it a nationwide scanning network now covering more than 200 locations. A crowded preventive health field. Function is far from alone in pursuing the idea that AI and continuous monitoring can catch disease before it starts. Neko Health, co-founded by Spotify's Daniel Ek, closed a $700 million Series C at nearly $7 billion in July 2026 to build its own scanning hardware and enter the U.S. Superpower raised $30 million at a $300 million-plus valuation using partner labs rather than owning the testing infrastructure, while Prenuvo has leaned entirely on whole-body MRI, generating roughly $250 million in annual revenue off $192 million raised. Function's bundled approach as a differentiator. Where those rivals specialize in one layer, such as imaging, labs, or software, Function combines labs, imaging, at-home draws and supplement guidance into a single membership, wagering that bundling wins out over point solutions. European competitors chasing the same thesis. European challengers are chasing the same thesis at a fraction of the capital. Paris-based Lucis, also backed by General Catalyst, raised $8.5 million to bring biomarker tracking to Europe, while Swiss startup Ahead Health raised $10 million to combine blood panels and MRI for launches in Germany and the Netherlands. UK's Numan has taken a different route into the same market, reporting $90 million in 2024 revenue from personalized preventive care. A stark capital intensity gap. Next to Function's $450 million non-dilutive cheque, the gap in capital intensity between the U.S. and European versions of the same idea is stark. "Function has created an entirely new approach to health. We believe the company is uniquely positioned to reach millions more people, and we're proud to support its next phase of growth," said Pranav Singhvi, partner and co-head of CVF at General Catalyst. What this Function Health General Catalyst funding structure means. Because CVF financing is structured as non-dilutive, revenue-linked capital rather than an equity stake, this deal does not reset Function's valuation, which stood at $2.5 billion after a $298 million Series B in November 2025 led by Redpoint Ventures, with participation from a16z, Aglaé Ventures, Battery Ventures, NFDG, and Roku founder Anthony Wood. Combined with roughly $350 million raised in prior equity rounds, Function has now raised more than $800 million across equity and non-dilutive financing. A growing market backdrop. According to Grand View Research, the global preventive healthcare technology market is expanding as diagnostics and AI push care earlier into a person's life, rather than after symptoms appear. Whether preventive testing becomes a genuine category of healthcare or a subscription for the worried wealthy is still unsettled. Function's membership costs a fraction of Neko's per-visit pricing, but at $365 a year with no insurance involved, the "millions more people" Singhvi describes will need convincing that data bought out of pocket is worth more than a doctor they cannot see. What to watch going forward. As Function deploys this Function Health General Catalyst funding to expand its bundled testing, imaging, and supplement platform, industry observers will likely watch whether the company's all-in-one approach proves more durable than the specialized, single-layer strategies pursued by Neko Health, Prenuvo, and Superpower. Given the significant capital gap between U.S. and European preventive health startups pursuing similar theses, how Function scales beyond its current 500,000 members may offer an important signal for whether consumer-paid preventive testing can become a mainstream category or remains a niche offering for those able to pay out of pocket.